Revenue by source
Exclusive License$0.00Duchenne Muscular Dystrophy License$0.00Collaboration Revenue$0.00Myotonic Dystrophy Type One License$0.00Collaborative Arrangement Material Rights$0.00Specified Target Option Material Right$0.00Grant$3.51MCollaborative Arrangement Material Rights Fourth Exclusive License$0.00Waiving Of Vertexs Material Right$0.00Myotonic Dystrophy Type One R And D Services$0.00License And Service$0.00
| Segment | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Exclusive License | - | - | - | $900.00M | - | - | - | - |
| Duchenne Muscular Dystrophy License | - | $151.10M | $151.10M | $151.10M | - | - | - | - |
| Collaboration Revenue | - | - | - | - | $436.00K | $370.00M | $35.00M | - |
| Myotonic Dystrophy Type One License | - | $51.30M | $51.30M | $51.30M | - | - | - | - |
| Collaborative Arrangement Material Rights | - | $46.70M | $46.70M | $46.70M | - | - | - | - |
| Specified Target Option Material Right | - | $11.80M | $11.80M | $11.80M | - | - | - | - |
| Grant | - | - | - | - | $762.00K | $1.21M | $2.31M | $3.51M |
| Collaborative Arrangement Material Rights Fourth Exclusive License | - | - | - | $6.70M | - | - | - | - |
| Waiving Of Vertexs Material Right | - | $6.70M | - | - | - | - | - | - |
| Myotonic Dystrophy Type One R And D Services | - | $1.10M | $1.10M | $1.10M | - | - | - | - |
| License And Service | $600.00K | - | - | - | - | - | - | - |